Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Update

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 13,100 shares, a drop of 16.0% from the March 31st total of 15,600 shares. Based on an average daily trading volume, of 16,600 shares, the short-interest ratio is currently 0.8 days.

Reviva Pharmaceuticals Trading Up 11.6 %

Shares of RVPHW stock opened at $0.53 on Friday. Reviva Pharmaceuticals has a 1-year low of $0.40 and a 1-year high of $3.00. The firm’s 50-day simple moving average is $0.67 and its 200-day simple moving average is $0.97.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.